Extemporaneous drug formulations

Clinical Therapeutics

Volumn 30, Issue 11, 2008, Pages 2112-2119

  Nahata, Milap C ^a   Allen Jr , Loyd V ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b International Journal of Pharmaceutical Compounding Inc   (United States)

Author keywords

clinical trials; compounding; extemporaneous formulations; pediatrics

Indexed keywords

ACETAZOLAMIDE; ALBENDAZOLE; AMFEBUTAMONE; AMIODARONE; AMITRIPTYLINE; ARGININE; ASPARTIC ACID; BIOTIN; BUSULFAN; CAPTOPRIL; CARBENICILLIN; CLINDAMYCIN; CLOBAZAM; CLONAZEPAM; CLONIDINE; COLESTYRAMINE; DANTROLENE; DEXAMETHASONE; ENALAPRIL; ETHAMBUTOL; ETHIONAMIDE; FAMCICLOVIR; FOLINIC ACID; GLUTAMINE; HYDROXYUREA; IRBESARTAN; LANSOPRAZOLE; LISINOPRIL; LOMUSTINE; UNINDEXED DRUG;

ADVERSE OUTCOME; ARTICLE; CHILD CARE; CLINICAL PRACTICE; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG POTENCY; DRUG RESEARCH; DRUG STABILITY; DRUG STERILITY; DRUG TOLERABILITY; HUMAN; MEDICAL LITERATURE; MEDICAL SOCIETY; NATIONAL HEALTH ORGANIZATION; PALATABILITY;

CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD HEALTH SERVICES; DOSAGE FORMS; DRUG COMPOUNDING; HUMANS; INFANT; INFANT, NEWBORN; PHARMACISTS; PROFESSIONAL ROLE;

EID: 57649200115     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2008.11.020     Document Type: Article

References (10)

1. Nahata M.C., and Taketomo C. Pediatrics. In: DiPiro J.T., Talbert R.L., Yee G.C., et al. (Eds). Pharmacotherapy: A Pathophysiologic Approach. 7th ed (2008), McGraw Hill, New York, NY 47-56
2. Blumer J.L. Off-label uses of drugs in children. Pediatrics 104 (1999) 598-602
3. Pai V., and Nahata M.C. Need for extemporaneous formulations in pediatric patients. J Pediatr Pharmacol Ther 6 (2001) 107-119
4. Nahata M.C., Pai V.B., and Hipple T.F. Pediatric Drug Formulations. 5th ed (2003), Harvey Whitney Books Co, Cincinnati, OH
5. Ghulam A., Keen K., Tuleu C., et al. Poor preservation efficacy versus quality and safety of pediatric extemporaneous liquids. Ann Pharmacother 41 (2007) 857-860
6. The American Academy of Pediatrics Committee on Drugs. "Inactive" ingredients in pharmaceutical products: Update (subject review). Pediatrics 99 (1997) 268-278
7. Pawar S., and Kumar A. Issues in the formulation of drugs for oral use in children: Role of excipients. Paediatr Drugs 4 (2002) 371-379
8. Standing J.F., Khaki Z.F., and Wong I.C. Poor formulation information in published pediatric drug trials. Pediatrics 116 (2005) e559-e562
9. HaaseM, LuedtkeS, RoblesJ, et al. Evalution of dosage form information provided in pediatric drug trial reports. Int J Phar Compound. In press.
10. ASHP Reports. Council on professional affairs. Am J Health-Syst Pharm 54 (1997) 819-826